Popular
- CME/CE Broadcast Replay
New Frontiers in Optimizing Patient Outcomes in Multiple Sclerosis: Strategies for Early Intervention to Address Progression Independent of Relapse
1.00 creditStephen Krieger, MD
Tirisham Gyang, MD
Augusto Miravalle, MD, FAAN
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Rhonda Cadena, MD, FNCS, FCCM
W. Brian Gibler, MD, FACEP, FACC, FAHA
Rhonda Cadena, MD, FNCS, FCCM
Adrian R. Parry-Jones, FRCP, PhD
Stuart Connolly, MD, FRCPC
W. Brian Gibler, MD, FACEP, FACC, FAHA
Adrian R. Parry-Jones, FRCP, PhD
Stuart Connolly, MD, FRCPC
W. Brian Gibler, MD, FACEP, FACC, FAHA
Greg Albers, MD
Rhonda Cadena, MD, FNCS, FCCM
Adrian R. Parry-Jones, FRCP, PhD
W. Brian Gibler, MD, FACEP, FACC, FAHA
Stuart Connolly, MD, FRCPC
Rhonda Cadena, MD, FNCS, FCCM
Greg Albers, MD
Valeria Caso, MD, PhD
Manesh R. Patel, MD
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
- MinuteCE®
What Types of Changes, If Any, Should We Expect with Amyloid-Targeting Therapy?
1.25 program creditsRichard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
- MinuteCE®
Idiopathic Hypersomnia and Cardiovascular Health: Too Much of a Good Thing?
1.00 program creditLogan Schneider, MD
Ana C. Krieger, MD
Alcibiades J. Rodriguez, MD, FAASM